India Must Move Beyond Generics to Secure Global Health Supply Chains in 2026
Piyush Goyal's Bharat Health Global Expo 2026 speech frames Indian pharma as a reliability partner for global healthcare supply chains. For healthcare systems, rebuilding API/KSM capability and moving beyond generics could reduce drug shortage risks. Policy emphasis on indigenous production may shift where hospitals and payers source critical medicines.